"ACS Laboratory's Potency 12 test is a completely different method from the industry standard because it specifically targets and separates Delta-8, Delta-9, and Delta-10 THC," said Aixia Sun, ACS Laboratory principal scientist and certified cannabis Lab director. "Many labs cannot test Delta-10 without a DEA license and often misidentify lesser-known analytes as Delta-9 in the process."

Delta-9 is a Schedule I illicit substance that cannot exceed 0.3% in hemp products, while Delta-8 and Delta-10 THC remain unregulated and in high demand. Delta-8 is becoming popular due to its distinct psychoactive effects and ability to bind with different receptors, leaving a person feeling relaxed but not confused. Delta-10 offers euphoria and increased focus, without the paranoia some users report from Delta-9. 

Hemp companies are rapidly developing Delta-8 and Delta-10 THC extracts, which they're bottling or infusing into edibles. 

"The problem is Delta-9 and Delta-8 THC are positional isomers, making it difficult for laboratories to separate the two during testing,” Sun said. “Two Delta-10 THC stereoisomers are also challenges because they are so elusive that laboratories often misidentify them for CBC or CBL using the industry-standard methodology.”

ACS Laboratory is committed to innovation, which is why it continuously develops new safety tests to ensure extracts are free from residual solvents. ACS Laboratory's Potency 12 Test is an add-on to the full panel Potency 11 that quantifies 12 total cannabinoids: Delta-10 THC, Delta-9 THC, Delta-8 THC, THCA, THCV, CBD, CBDA, CBDV, CBG, CBGA, CBC, and CBN.

"As the hemp industry evolves, laboratories must continuously re-evaluate methods to ensure they are producing valid results," said Roger Brown, president and founder of ACS Laboratory. "Laboratories who fail to rise to the occasion will ultimately put their clients at risk."

This article was originally posted on www.cannabisproductsinsider.com